Diagnosis and Evaluation | Etiology and PathogenesisMolecular Oncology


Neurol Sci. 2003 Jun;24(2):70-3. (Laboratory Investigation)


Abstract

Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable

Ribom D, Larsson A, Pietras K, Smits A

Department of Neuroscience, Neurology, University Hospital, University of Uppsala, SE-751 85 Uppsala, Sweden.

Platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2) are involved in the development of grade 2 gliomas. 

The aim of the present study was to determine the presence of these growth factors in the cerebrospinal fluid (CSF) and to assess their usefulness as biological markers. 
CSF was collected from 7 adult patients with newly diagnosed supratentorial low-grade gliomas by lumbar puncture and was analysed together with matched serum samples using radioreceptor and enzyme-linked immunosorbant assays. 
Neither PDGF nor VEGF were detected in the CSF, and FGF-2 was measurable at extremely low concentrations in only 2 of 7 patients. 
Serum levels were within normal limits. 
We conclude that these growth factors are not released into the CSF in any significant amounts and are therefore not suitable as biological markers in grade 2 gliomas.

PMID: 12827542 [PubMed - indexed for MEDLINE]


Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12827542


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP